Neurostimulator clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
RNS System RESPONSE Study
open to eligible people ages 12-17
To demonstrate that the RNS System is safe and effective as an adjunctive therapy in individuals age 12 through 17 years with medically refractory partial onset epilepsy.
at UCLA
Last updated: